Ann: RAD agreement with NorthStar for supply of Actinium-225, page-54

First 54 Last

Share
Profile

Follow
Tradingdreamz88

5,110 Posts.

963

26/05/24

13:03

Post #: 74012661
Share

Originally posted by Steini: ↑

I am neither a RAD nor a PH employee and I am down on my RAD investment too but I am able to understand the difference between a sp and a company performance. Normally the sp should reflect the performance but this is not the case. Not just for RAD, it applies to the entire world wide bio-comps that have no revenue / profit. They get valued on PE ratios and that means ZERO worth. All IP, developments and so on are currently ignored. That's what it is. There will be a time when we get back to the market looking at fundamentals other than income but that's still some time in the future. The smarties load up now to sell when the herd buys. That requires patience and discipline and to put emotions aside, like the computer of the big guys do. The lower the machines can buy the "happier" they are. We get terrified seeing the sp drifting lower as we just look at the 1 day time frame instead of years.

Can't guarantee the sp reversing today or tomorrow, but it should happen over the next 12 to 18 months. We are in good hands here.

I made my millions by being patient, took a long time and a lot of failures to learn from. Lost some fortunes due to the GFC and Fukushima but always recovered stronger by acting rationally and taking advantages of down turns, such like this one.

Not convinced or worried, sell. No point holding when having sleepless nights.

GLTA

Expand

18months- how's this looking ?
1 Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 9 more messages in this thread...

First 54 Last

Add RAD (ASX) to my watchlist

(20min delay)
Last 2.7¢		Change -0.001(1.85%)		Mkt cap ! $58.66M

Open	High	Low	Value	Volume
2.8¢	2.8¢	2.6¢	$69.49K	2.567M

Buyers (Bids)

No.	Vol.	Price($)
7	2648873	2.6¢

Sellers (Offers)

Price($)	Vol.	No.
2.7¢	100374	3

View Market Depth

No.	Vol.	Price($)
7	2648873	0.026
9	1281713	0.025
3	440440	0.024
6	652081	0.023
3	1073520	0.022

Price($)	Vol.	No.
0.027	100374	3
0.028	419062	3
0.029	398935	3
0.030	483825	5
0.031	422423	3

Last trade - 13.31pm 07/10/2024 (20 minute delay)

RAD (ASX) Chart

Ann: RAD agreement with NorthStar for supply of Actinium-225, page-54

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: RAD agreement with NorthStar for supply of Actinium-225, page-54

Top Stories

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News